查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1855818

无细胞DNA（cfDNA）试剂盒全球市场报告（2025年）

Cell-Free DNA (cfDNA) Kits Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，无细胞DNA（cfDNA）试剂盒的市场规模迅速扩张，从2024年的16亿美元成长到2025年的18亿美元，复合年增长率达12.6%。这段时期的成长主要得益于诊断实验室的增加、肿瘤学应用的日益普及、移植和妇科应用的广泛使用，以及人工智慧在诊断领域日益增长的整合。

预计未来几年，无细胞DNA（cfDNA）试剂盒市场将快速成长，到2029年市场规模将达到28.6亿美元，复合年增长率（CAGR）为12.3%。预测期内的成长预计将受到以下因素的推动：数位聚合酵素链锁反应（ DPRC）的日益普及、即时DPRC的广泛应用、在其他疾病领域的应用拓展、诊断实验室数量的增长以及对无创产前检测需求的上升。预测期内的主要趋势包括：单细胞基因组学的发展、自动化实验室工作流程的整合、基于蛋白质组学的诊断技术的进步、代谢体学分析的创新以及无酶核酸检测方法的开发。

预计未来几年，遗传疾病的日益普遍将推动无细胞DNA (cfDNA) 检测试剂盒市场的成长。遗传疾病是一种由一个或多个基因突变或染色体异常所导致的DNA改变所引起的疾病。这些疾病发生率的上升主要是由于生活方式的改变以及污染和不良饮食等环境因素造成的，这些因素会导致基因突变并加剧遗传疾病。无细胞DNA (cfDNA) 检测试剂盒透过分析血液和其他体液中存在的DNA片段，可以实现对遗传异常的非侵入性早期检测。这项技术能够实现快速诊断，并帮助医疗保健提供者确定准确的治疗方案。例如，美国疾病管制与预防中心 (CDC) 在2024年11月报告称，美国大约每33名新生儿中就有1名患有先天性异常，其中许多与遗传有关。因此，遗传疾病日益普遍正在刺激cfDNA检测试剂盒的需求。

cfDNA检测试剂盒市场的主要企业正致力于开发采用基于数位聚合酵素链锁反应（PCR）的绝对定量方法的创新产品，以提高cfDNA分析的灵敏度和准确性。基于数位PCR的绝对定量方法能够更准确地检测低频基因突变，并提高检测结果的一致性，使其适用于癌症诊断、产前检测和移植排斥反应监测等重要应用。例如，2024年6月，总部位于匈牙利的分子诊断公司Omixon推出了HoloGRAFT ONE，这是一款仅供研究使用的试剂盒，旨在监测移植后供体来源的游离DNA（dd-cfDNA）。该试剂盒利用专有的遗传标记和数位PCR技术来区分供体DNA和受体DNA，并透过拷贝数变异来测量dd-cfDNA的绝对和相对含量。这项创新检测的目标是为临床医生提供准确的cfDNA数据，从而实现移植排斥反应的早期检测、改善患者监测并支持个人化的移植后护理。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税，以及新冠疫情及其復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球无细胞DNA（cfDNA）试剂盒：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 终端用户产业分析
  • 全球无细胞DNA（cfDNA）试剂盒市场：成长率分析
  • 全球无细胞DNA（cfDNA）试剂盒市场表现：规模与成长，2019-2024年
  • 全球无细胞DNA（cfDNA）试剂盒市场预测：规模与成长，2024-2029年，2034年
  • 全球无细胞DNA（cfDNA）试剂盒：潜在市场规模（TAM）

第六章 市场细分

  • 全球无细胞DNA（cfDNA）试剂盒市场按产品类型、性能和预测划分，2019-2024年、2024-2029年、2034年
  • 血浆游离DNA (cfDNA) 试剂盒
  • 血清游离DNA (cfDNA) 检测试剂盒
  • 尿液无细胞DNA (cfDNA) 检测试剂盒
  • 其他产品
  • 全球无细胞DNA（cfDNA）试剂盒市场：依技术、效能和预测划分，2019-2024年、2024-2029年、2034年
  • 次世代定序仪（NGS）
  • 聚合酵素链锁反应（PCR）
  • 微阵列技术
  • 数位聚合酵素链锁反应（PCR）
  • 全球无细胞DNA（cfDNA）试剂盒市场：按应用、性能和预测划分，2019-2024年、2024-2029年、2034年
  • 癌症诊断剂
  • 产前检查
  • 监测移植排斥反应
  • 非侵入性疾病检测
  • 全球无细胞DNA（cfDNA）试剂盒市场按分销管道划分：实际数据和预测，2019-2024年、2024-2029年、2034年
  • 直销
  • 零售药房
  • 线上销售
  • 经销商
  • 全球无细胞DNA（cfDNA）试剂盒市场按最终用户、性能和预测划分，2019-2024年、2024-2029年、2034年
  • 医院
  • 研究所
  • 诊断实验室
  • 学术机构
  • 全球无细胞DNA (cfDNA) 试剂盒市场：细分市场 血浆无细胞DNA试剂盒：按类型、性能和预测，2019-2024年、2024-2029年、2034年
  • 单链DNA试剂盒
  • 双链DNA试剂盒
  • 高灵敏度DNA检测试剂盒
  • 快速DNA萃取试剂盒
  • 全球无细胞DNA (cfDNA) 试剂盒市场：细分市场 血清无细胞DNA试剂盒：按类型、性能和预测，2019-2024年、2024-2029年、2034年
  • 小规模DNA生产试剂盒
  • 高产量DNA试剂盒
  • 自动化DNA检测试剂盒
  • 手动DNA萃取试剂盒
  • 全球无细胞DNA (cfDNA) 试剂盒市场：细分市场 尿液无细胞DNA试剂盒：按类型、性能和预测，2019-2024年、2024-2029年、2034年
  • 早期检测DNA试剂盒
  • 浓缩DNA试剂盒
  • 高纯度DNA试剂盒
  • 长期稳定DNA试剂盒
  • 全球无细胞DNA（cfDNA）试剂盒市场：按产品、类型、性能和预测进行细分，2019-2024年、2024-2029年、2034年
  • 唾液DNA检测试剂盒
  • 脑脊髓液DNA检测试剂盒
  • 羊水DNA检测试剂盒
  • 组织来源DNA试剂盒

第七章 区域和国家分析

  • 全球无细胞DNA（cfDNA）试剂盒市场：按地区、性能和预测划分，2019-2024年、2024-2029年、2034年
  • 全球无细胞DNA（cfDNA）试剂盒市场按国家/地区、性能和预测划分，2019-2024年、2024-2029年、2034年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第十八章：法国市场

第十九章：义大利市场

第二十章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第三十章：竞争格局与公司概况

  • 无细胞DNA（cfDNA）试剂盒市场：竞争格局
  • 无细胞DNA（cfDNA）试剂盒市场：公司简介
    • F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • QIAGEN NV
  • Natera Inc.
  • Myriad Genetics Inc.
  • Guardant Health Inc.
  • Bioneer Corporation
  • Streck Inc.
  • Freenome Holdings Inc.
  • GRAIL Inc.
  • Zymo Research Corporation
  • Geneseeq Technology Inc
  • Covaris LLC
  • Active Motif Inc.
  • Norgen Biotek Corp
  • AMSBIO LLC
  • EpiGentek Group Inc.

第32章 全球市场竞争基准化分析与仪錶板

第33章 重大併购

第34章 近期市场趋势

第35章：高潜力市场国家、细分市场与策略

  • 无细胞DNA（cfDNA）试剂盒市场2029：提供新机会的国家
  • 无细胞DNA（cfDNA）试剂盒市场展望（2029）：新兴细分市场机会
  • 无细胞DNA（cfDNA）试剂盒市场2029年：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章附录

简介目录
Product Code: r38467

Cell-free DNA (cfDNA) kits are laboratory tools designed to isolate and analyze fragmented DNA circulating in blood or other body fluids. They support non-invasive genetic testing by providing high-quality DNA for applications such as prenatal screening, cancer diagnostics, and transplant monitoring. These kits simplify sample preparation and enhance accuracy in downstream molecular analysis.

The primary product types in the cell-free DNA (cfDNA) kits market include plasma cfDNA kits, serum cfDNA kits, urine cfDNA kits, and others. Plasma cfDNA kits are designed to isolate and analyze DNA fragments circulating in plasma, the liquid component of blood. Key technologies include next-generation sequencing (NGS), polymerase chain reaction (PCR), microarray technology, and digital PCR. Major applications encompass cancer diagnostics, prenatal testing, transplant rejection monitoring, and non-invasive disease detection. Distribution channels consist of direct sales, retail pharmacies, online platforms, and distributors, while end users include hospitals, research laboratories, diagnostic laboratories, and academic institutions.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The cell-free DNA (cfDNA) market research report is one of a series of new reports from The Business Research Company that provides cell-free DNA (cfDNA) market statistics, including cell-free DNA (cfDNA) industry global market size, regional shares, competitors with a cell-free DNA (cfDNA) market share, detailed cell-free DNA (cfDNA) market segments, market trends and opportunities, and any further data you may need to thrive in the cell-free DNA (cfDNA) industry. The cell-free DNA (cfDNA) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cell-free DNA (cfDNA) kits market size has grown rapidly in recent years. It will grow from $1.60 billion in 2024 to $1.80 billion in 2025 at a compound annual growth rate (CAGR) of 12.6%. Growth in the historic period was driven by the increasing number of diagnostic laboratories, greater adoption of oncology applications, wider use in transplantation and gynecology applications, and rising integration of artificial intelligence in diagnostics.

The cell-free DNA (cfDNA) kits market size is expected to see rapid growth in the next few years. It will grow to $2.86 billion in 2029 at a compound annual growth rate (CAGR) of 12.3%. Growth in the forecast period is expected to be supported by rising adoption of digital polymerase chain reaction, increased use of real-time polymerase chain reaction, expanding applications in other disease areas, growth in the number of diagnostic laboratories, and higher demand for non-invasive prenatal testing. Key trends anticipated for the forecast period include advancements in single-cell genomics, integration of automated laboratory workflows, progress in proteomics-based diagnostics, innovation in metabolomics analysis, and the development of enzyme-free nucleic acid detection methods.

The increasing prevalence of genetic disorders is expected to drive the growth of the cell-free DNA (cfDNA) kits market in the coming years. Genetic disorders are medical conditions caused by alterations in a person's DNA, which can result from mutations in one or more genes, or chromosomal abnormalities. The rising occurrence of these disorders is largely due to lifestyle changes and environmental factors such as pollution and poor diet, which can either cause genetic mutations or worsen inherited conditions. Cell-free DNA (cfDNA) kits enable early, non-invasive detection of genetic abnormalities by analyzing DNA fragments present in blood or other body fluids. This technology facilitates quicker diagnoses and allows healthcare providers to make accurate treatment decisions. For example, the Centers for Disease Control and Prevention (CDC), a U.S.-based government agency, reported in November 2024 that about 1 in every 33 newborns in the U.S. is born with a birth defect, many of which are genetically related. As a result, the increasing prevalence of genetic disorders is fueling demand for cfDNA kits.

Leading companies in the cfDNA kits market are concentrating on developing innovative products that use digital polymerase chain reaction (PCR)-based absolute quantification to enhance the sensitivity and accuracy of cfDNA analysis. Digital PCR-based absolute quantification allows for the precise detection of low-frequency genetic variants with improved consistency, making it suitable for critical applications such as cancer diagnostics, prenatal testing, and monitoring transplant rejection. For example, in June 2024, Omixon, a molecular diagnostics company based in Hungary, introduced HoloGRAFT ONE, a research-use-only kit designed to monitor donor-derived cell-free DNA (dd-cfDNA) post-transplant. This kit utilizes proprietary genetic markers and digital PCR to differentiate donor DNA from the recipient's DNA, measuring both absolute and relative amounts of dd-cfDNA through copy-number variants. The goal of this innovative test is to enable the early detection of transplant rejection, improve patient monitoring, and support personalized post-transplant care by providing clinicians with precise cfDNA data.

In February 2022, Labcorp Holdings Inc., a U.S.-based life sciences company, acquired Personal Genome Diagnostics Inc. for an undisclosed amount. This acquisition allows Labcorp to integrate Personal Genome Diagnostics' advanced genomic technologies to enhance its cancer diagnostic offerings and bolster its precision medicine capabilities. Personal Genome Diagnostics Inc. is a U.S.-based company specializing in cell-free DNA (cfDNA) kits, with a focus on circulating tumor DNA (ctDNA) for cancer research and diagnostics.

Major players in the cell-free DNA (cfDNA) kits market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V, Natera Inc., Myriad Genetics Inc., Guardant Health Inc., Bioneer Corporation, Streck Inc., Freenome Holdings Inc., GRAIL Inc., Zymo Research Corporation, Geneseeq Technology Inc, Covaris LLC, Active Motif Inc., Norgen Biotek Corp, AMSBIO LLC, EpiGentek Group Inc., Paragon Genomics Inc., Suzhou Beaver Biomedical Engineering.

North America was the largest region in the cell-free DNA (cfDNA) kits market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in cell-free DNA (cfDNA) kits report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the cell-free DNA (cfDNA) kits market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cell-free DNA (cfDNA) kits market consists of revenues earned by entities by providing services such as purification services, bulk services, quality control (QC) services, data integration services, and custom biomarker discovery services. The market value includes the value of related goods sold by the service provider or included within the service offering. The cell-free DNA (cfDNA) kits market also includes sales of plasma separation consumables, liquid biopsy assay kits, serum preparation kits, concentration kits, and bisulfite conversion and methylation kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cell-Free DNA (cfDNA) Kits Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cell-free dna (cfdna) kits market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cell-free dna (cfdna) kits ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cell-free dna (cfdna) kits market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Plasma Cell-Free DNA (Cfdna) Kits; Serum Cell-Free DNA (Cfdna) Kits; Urine Cell-Free DNA (Cfdna) Kits; Other Products
  • 2) By Technology: Next-Generation Sequencing (NGS); Polymerase Chain Reaction (PCR); Microarray Technology; Digital Polymerase Chain Reaction(PCR)
  • 3) By Application: Cancer Diagnostics; Prenatal Testing; Transplant Rejection Monitoring; Non-Invasive Disease Detection
  • 4) By Distribution Channel: Direct Sales; Retail Pharmacies; Online Sales; Distributors
  • 5) By End User: Hospitals; Research Laboratories; Diagnostic Laboratories; Academic Institutions
  • Subsegments:
  • 1) By Plasma Cell-Free DNA Kits: Single-Stranded DNA Kits; Double-Stranded DNA Kits; High-Sensitivity DNA Kits; Rapid Extraction DNA Kits
  • 2) By Serum Cell-Free DNA Kits: Low-Volume DNA Kits; High-Yield DNA Kits; Automated DNA Kits; Manual Extraction DNA Kits
  • 3) By Urine Cell-Free DNA Kits: Early Detection DNA Kits; Concentration DNA Kits; High-Purity DNA Kits; Long-Term Stability DNA Kits
  • 4) By Other Products: Saliva DNA Kits; Cerebrospinal Fluid DNA Kits; Amniotic Fluid DNA Kits; Tissue-Derived DNA Kits
  • Companies Mentioned: F. Hoffmann-La Roche Ltd; Thermo Fisher Scientific Inc.; Agilent Technologies Inc.; Illumina Inc.; Bio-Rad Laboratories Inc.; QIAGEN N.V; Natera Inc.; Myriad Genetics Inc.; Guardant Health Inc.; Bioneer Corporation; Streck Inc.; Freenome Holdings Inc.; GRAIL Inc.; Zymo Research Corporation; Geneseeq Technology Inc; Covaris LLC; Active Motif Inc.; Norgen Biotek Corp; AMSBIO LLC; EpiGentek Group Inc.; Paragon Genomics Inc.; Suzhou Beaver Biomedical Engineering.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cell-Free DNA (cfDNA) Kits Market Characteristics

3. Cell-Free DNA (cfDNA) Kits Market Trends And Strategies

4. Cell-Free DNA (cfDNA) Kits Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Cell-Free DNA (cfDNA) Kits Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Cell-Free DNA (cfDNA) Kits PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Cell-Free DNA (cfDNA) Kits Market Growth Rate Analysis
  • 5.4. Global Cell-Free DNA (cfDNA) Kits Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Cell-Free DNA (cfDNA) Kits Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Cell-Free DNA (cfDNA) Kits Total Addressable Market (TAM)

6. Cell-Free DNA (cfDNA) Kits Market Segmentation

  • 6.1. Global Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Plasma Cell-Free DNA (Cfdna) Kits
  • Serum Cell-Free DNA (Cfdna) Kits
  • Urine Cell-Free DNA (Cfdna) Kits
  • Other Products
  • 6.2. Global Cell-Free DNA (cfDNA) Kits Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Next-Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Microarray Technology
  • Digital Polymerase Chain Reaction(PCR)
  • 6.3. Global Cell-Free DNA (cfDNA) Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cancer Diagnostics
  • Prenatal Testing
  • Transplant Rejection Monitoring
  • Non-Invasive Disease Detection
  • 6.4. Global Cell-Free DNA (cfDNA) Kits Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Direct Sales
  • Retail Pharmacies
  • Online Sales
  • Distributors
  • 6.5. Global Cell-Free DNA (cfDNA) Kits Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Research Laboratories
  • Diagnostic Laboratories
  • Academic Institutions
  • 6.6. Global Cell-Free DNA (cfDNA) Kits Market, Sub-Segmentation Of Plasma Cell-Free DNA Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Stranded DNA Kits
  • Double-Stranded DNA Kits
  • High-Sensitivity DNA Kits
  • Rapid Extraction DNA Kits
  • 6.7. Global Cell-Free DNA (cfDNA) Kits Market, Sub-Segmentation Of Serum Cell-Free DNA Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Low-Volume DNA Kits
  • High-Yield DNA Kits
  • Automated DNA Kits
  • Manual Extraction DNA Kits
  • 6.8. Global Cell-Free DNA (cfDNA) Kits Market, Sub-Segmentation Of Urine Cell-Free DNA Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Early Detection DNA Kits
  • Concentration DNA Kits
  • High-Purity DNA Kits
  • Long-Term Stability DNA Kits
  • 6.9. Global Cell-Free DNA (cfDNA) Kits Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Saliva DNA Kits
  • Cerebrospinal Fluid DNA Kits
  • Amniotic Fluid DNA Kits
  • Tissue-Derived DNA Kits

7. Cell-Free DNA (cfDNA) Kits Market Regional And Country Analysis

  • 7.1. Global Cell-Free DNA (cfDNA) Kits Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Cell-Free DNA (cfDNA) Kits Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cell-Free DNA (cfDNA) Kits Market

  • 8.1. Asia-Pacific Cell-Free DNA (cfDNA) Kits Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Cell-Free DNA (cfDNA) Kits Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Cell-Free DNA (cfDNA) Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cell-Free DNA (cfDNA) Kits Market

  • 9.1. China Cell-Free DNA (cfDNA) Kits Market Overview
  • 9.2. China Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Cell-Free DNA (cfDNA) Kits Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Cell-Free DNA (cfDNA) Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cell-Free DNA (cfDNA) Kits Market

  • 10.1. India Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Cell-Free DNA (cfDNA) Kits Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Cell-Free DNA (cfDNA) Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cell-Free DNA (cfDNA) Kits Market

  • 11.1. Japan Cell-Free DNA (cfDNA) Kits Market Overview
  • 11.2. Japan Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Cell-Free DNA (cfDNA) Kits Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Cell-Free DNA (cfDNA) Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cell-Free DNA (cfDNA) Kits Market

  • 12.1. Australia Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Cell-Free DNA (cfDNA) Kits Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Cell-Free DNA (cfDNA) Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cell-Free DNA (cfDNA) Kits Market

  • 13.1. Indonesia Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Cell-Free DNA (cfDNA) Kits Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Cell-Free DNA (cfDNA) Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cell-Free DNA (cfDNA) Kits Market

  • 14.1. South Korea Cell-Free DNA (cfDNA) Kits Market Overview
  • 14.2. South Korea Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Cell-Free DNA (cfDNA) Kits Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Cell-Free DNA (cfDNA) Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cell-Free DNA (cfDNA) Kits Market

  • 15.1. Western Europe Cell-Free DNA (cfDNA) Kits Market Overview
  • 15.2. Western Europe Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Cell-Free DNA (cfDNA) Kits Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Cell-Free DNA (cfDNA) Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cell-Free DNA (cfDNA) Kits Market

  • 16.1. UK Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Cell-Free DNA (cfDNA) Kits Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Cell-Free DNA (cfDNA) Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cell-Free DNA (cfDNA) Kits Market

  • 17.1. Germany Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Cell-Free DNA (cfDNA) Kits Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Cell-Free DNA (cfDNA) Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cell-Free DNA (cfDNA) Kits Market

  • 18.1. France Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Cell-Free DNA (cfDNA) Kits Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Cell-Free DNA (cfDNA) Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cell-Free DNA (cfDNA) Kits Market

  • 19.1. Italy Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Cell-Free DNA (cfDNA) Kits Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Cell-Free DNA (cfDNA) Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cell-Free DNA (cfDNA) Kits Market

  • 20.1. Spain Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Cell-Free DNA (cfDNA) Kits Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Cell-Free DNA (cfDNA) Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cell-Free DNA (cfDNA) Kits Market

  • 21.1. Eastern Europe Cell-Free DNA (cfDNA) Kits Market Overview
  • 21.2. Eastern Europe Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Cell-Free DNA (cfDNA) Kits Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Cell-Free DNA (cfDNA) Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cell-Free DNA (cfDNA) Kits Market

  • 22.1. Russia Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Cell-Free DNA (cfDNA) Kits Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Cell-Free DNA (cfDNA) Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cell-Free DNA (cfDNA) Kits Market

  • 23.1. North America Cell-Free DNA (cfDNA) Kits Market Overview
  • 23.2. North America Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Cell-Free DNA (cfDNA) Kits Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Cell-Free DNA (cfDNA) Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cell-Free DNA (cfDNA) Kits Market

  • 24.1. USA Cell-Free DNA (cfDNA) Kits Market Overview
  • 24.2. USA Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Cell-Free DNA (cfDNA) Kits Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Cell-Free DNA (cfDNA) Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cell-Free DNA (cfDNA) Kits Market

  • 25.1. Canada Cell-Free DNA (cfDNA) Kits Market Overview
  • 25.2. Canada Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Cell-Free DNA (cfDNA) Kits Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Cell-Free DNA (cfDNA) Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cell-Free DNA (cfDNA) Kits Market

  • 26.1. South America Cell-Free DNA (cfDNA) Kits Market Overview
  • 26.2. South America Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Cell-Free DNA (cfDNA) Kits Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Cell-Free DNA (cfDNA) Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cell-Free DNA (cfDNA) Kits Market

  • 27.1. Brazil Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Cell-Free DNA (cfDNA) Kits Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Cell-Free DNA (cfDNA) Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cell-Free DNA (cfDNA) Kits Market

  • 28.1. Middle East Cell-Free DNA (cfDNA) Kits Market Overview
  • 28.2. Middle East Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Cell-Free DNA (cfDNA) Kits Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Cell-Free DNA (cfDNA) Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cell-Free DNA (cfDNA) Kits Market

  • 29.1. Africa Cell-Free DNA (cfDNA) Kits Market Overview
  • 29.2. Africa Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Cell-Free DNA (cfDNA) Kits Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Cell-Free DNA (cfDNA) Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cell-Free DNA (cfDNA) Kits Market Competitive Landscape And Company Profiles

  • 30.1. Cell-Free DNA (cfDNA) Kits Market Competitive Landscape
  • 30.2. Cell-Free DNA (cfDNA) Kits Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Cell-Free DNA (cfDNA) Kits Market Other Major And Innovative Companies

  • 31.1. QIAGEN N.V
  • 31.2. Natera Inc.
  • 31.3. Myriad Genetics Inc.
  • 31.4. Guardant Health Inc.
  • 31.5. Bioneer Corporation
  • 31.6. Streck Inc.
  • 31.7. Freenome Holdings Inc.
  • 31.8. GRAIL Inc.
  • 31.9. Zymo Research Corporation
  • 31.10. Geneseeq Technology Inc
  • 31.11. Covaris LLC
  • 31.12. Active Motif Inc.
  • 31.13. Norgen Biotek Corp
  • 31.14. AMSBIO LLC
  • 31.15. EpiGentek Group Inc.

32. Global Cell-Free DNA (cfDNA) Kits Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cell-Free DNA (cfDNA) Kits Market

34. Recent Developments In The Cell-Free DNA (cfDNA) Kits Market

35. Cell-Free DNA (cfDNA) Kits Market High Potential Countries, Segments and Strategies

  • 35.1 Cell-Free DNA (cfDNA) Kits Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Cell-Free DNA (cfDNA) Kits Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Cell-Free DNA (cfDNA) Kits Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer